IFC & Insurance Marketing’s AbbVie ABBV Stock Holding History

IFC & Insurance Marketing’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-135	Closed	-$31K	–	74
2025 Q4	$31K	Buy	+135	New	+$30.8K	0.03%	226

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

IFC & Insurance Marketing's ABBV Position: Q1 2026 in Review

IFC & Insurance Marketing sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 135 shares — an estimated $31K sold.

IFC & Insurance Marketing first reported a position in ABBV in Q4 2025 and held it in 1 quarter. The position peaked at $31K in Q4 2025. 4,097 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

IFC & Insurance Marketing reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
IFC & Insurance Marketing sold 135 AbbVie shares in Q1 2026, an estimated $31K.
IFC & Insurance Marketing first reported a position in AbbVie in Q4 2025 and held it in 1 quarter.
IFC & Insurance Marketing's AbbVie position peaked at $31K in Q4 2025.
4,097 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on IFC & Insurance Marketing's 13F filing for Q1 2026, filed 17 Apr 2026.